Moreover, we recently demonstrated that reduced expression of SKP1, CUL1 and RBX1 prevents Cyclin E1 degradation leading to an increase in abundance that induces CIN and promotes cellular transformation in colorectal and ovarian cancer contexts [9,10,12]. Here, RBX1 is linked to ovarian cancer.